{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:00:57Z","timestamp":1781737257056,"version":"3.54.5"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China Youth Program","award":["No.81802580"],"award-info":[{"award-number":["No.81802580"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,11]]},"abstract":"<jats:p>This study assesses the clinical value of magnetic resonance imaging (MRI) and transrectal ultrasonography (TRUS) cognitive fusion-guided transperineal prostate biopsy for prostate cancer detection. A total of 110 patients with suspected prostate cancer admitted from June 2019 to June 2021 were included. All patients underwent systematic TRUS-guided biopsy and MRI\u2013TRUS cognitive fusion-guided transperineal biopsy. The prostate cancer detection rate, distribution at different total prostate specific antigen levels and risk levels, and postoperative complication incidence were analyzed. Of 110 patients, 63 were confirmed with prostate cancer. The MRI\u2013TRUS fusion-guided biopsy achieved a higher positive detection rate (54.55%) than systematic puncture biopsy (51.82%), although the difference was not statistically significant (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). There was no significant difference in positive rates across total prostate specific antigen levels (&lt;4, 4\u201310, 10\u201320, 20\u201350\u2009ng\/mL) or among Gleason score-based risk groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). Using systematic puncture biopsy as the gold standard, MRI\u2013TRUS fusion-guided biopsy showed an accuracy of 79.09%, sensitivity of 79.64%, specificity of 79.61%, positive predictive value of 72.49%, and negative predictive value of 86.91%. Complications, including hematuria, bloody stool, fever, and dysuria, were mild, managed with antibiotics, catheterization, and rehydration, with no significant difference in complication rates (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). MRI\u2013TRUS fusion-guided transperineal prostate biopsy demonstrates higher detection efficiency, reduces needle use, minimizes postoperative complications, and offers improved safety compared to systematic puncture biopsy.<\/jats:p>","DOI":"10.1097\/md.0000000000043049","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T18:01:45Z","timestamp":1752516105000},"page":"e43049","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Clinical value of transperineal prostate biopsy guided by cognitive fusion of magnetic resonance and transrectal ultrasound"],"prefix":"10.1097","volume":"104","author":[{"given":"Fan","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Urology, The Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2209-0316","authenticated-orcid":false,"given":"Yeqing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250812","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2022.03.033","article-title":"Smoking and risk of prostate cancer and prostate cancer death: a pooled study.","volume":"83","author":"Jochems","year":"2023","journal-title":"Eur Urol"},{"key":"R2-20250812","first-page":"394","article-title":"Prostate cancer in lebanon: incidence, temporal trends, and comparison to countries from different regions in the world.","volume":"28","author":"Lakkis","year":"2021","journal-title":"Cancer Control"},{"key":"R3-20250812","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1016\/j.jval.2021.04.1177","article-title":"PUK9 economic evaluation of prostate-specific antigen screening for prostate cancer in China.","volume":"24","author":"Qin","year":"2021","journal-title":"Value Health"},{"key":"R4-20250812","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/JU.0000000000001697","article-title":"Robotic salvage lymph node dissection in recurrent prostate cancer: lessons learned from 68 cases and implications for future clinical management.","volume":"206","author":"Linxweiler","year":"2021","journal-title":"J Urol"},{"key":"R5-20250812","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/MOU.0000000000000694","article-title":"Chemotherapy, not androgen receptor-targeted therapy should be used upfront for metastatic hormone-sensitive prostate cancer. CON: novel oral agents provide an attractive alternative to chemotherapy in metastatic hormone-sensitive prostate cancer.","volume":"30","author":"Condon","year":"2020","journal-title":"Curr Opin Urol"},{"key":"R6-20250812","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/JU.0000000000001841","article-title":"Apalutamide plus androgen deprivation therapy for metastatic castration-sensitive prostate cancer: analysis of pain and fatigue in the phase 3 TITAN study.","volume":"206","author":"Agarwal","year":"2021","journal-title":"J Urol"},{"key":"R7-20250812","doi-asserted-by":"crossref","first-page":"40965","DOI":"10.1136\/bmjopen-2020-040965","article-title":"What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic review.","volume":"10","author":"Kawa","year":"2020","journal-title":"BMJ Open"},{"key":"R8-20250812","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaoncol.2020.7589","article-title":"Re: Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial.","volume":"7","author":"Klotz","year":"2021","journal-title":"JAMA Oncol"},{"key":"R9-20250812","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.theriogenology.2020.12.020","article-title":"Effect of dose and timing of prostaglandin F2\u03b1 treatments during a 7-d Ovsynch protocol on progesterone concentration at the end of the protocol and pregnancy outcomes in lactating Holstein cows - ScienceDirect.","volume":"162","author":"Tippenhauer","year":"2021","journal-title":"Theriogenology"},{"key":"R10-20250812","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/JU.0000000000001361","article-title":"Clinical utility of 4kscore, exosomedx and magnetic resonance imaging for the early detection of high-grade prostate cancer.","volume":"205","author":"de la Calle","year":"2021","journal-title":"J Urol"},{"key":"R11-20250812","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/bco2.172","article-title":"Selecting patients for magnetic resonance imaging cognitive versus ultrasound fusion biopsy of the prostate: a within-patient comparison.","volume":"3","author":"Hayes","year":"2022","journal-title":"BJUI Compass"},{"key":"R12-20250812","first-page":"802","article-title":"Diagnosis and treatment of male urethritis in urology and andrology: a status survey.","volume":"25","author":"Zhou","year":"2019","journal-title":"Natl J Androl"},{"key":"R13-20250812","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1148\/radiol.13122233","article-title":"Prostate cancer localization using multiparametric mr imaging: comparison of prostate imaging reporting and data system (PI-RADS) and likert scales.","volume":"269","author":"Rosenkrantz","year":"2013","journal-title":"Radiology"},{"key":"R14-20250812","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejrad.2019.05.006","article-title":"Clinically significant prostate cancer detection on MRI: a radiomic shape features study.","volume":"116","author":"Cuocolo","year":"2019","journal-title":"Eur J Radiol"},{"key":"R15-20250812","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system.","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R16-20250812","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1002\/cam4.3320","article-title":"Clinicopathological characteristics of localized prostate cancer in younger men aged\u226450 years treated with radical prostatectomy in the PSA era: a systematic review and meta\u2010analysis.","volume":"9","author":"Zheng","year":"2020","journal-title":"Cancer Med"},{"key":"R17-20250812","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.eururo.2021.02.029","article-title":"The impact of previous prostate surgery on surgical outcomes for patients treated with robot-assisted radical cystectomy for bladder cancer.","volume":"80","author":"Rosiello","year":"2021","journal-title":"Eur Urol"},{"key":"R18-20250812","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/jocn.15981","article-title":"Predictors for lower urinary tract symptoms in patients underwent radical prostatectomy: implications for postoperative nursing care.","volume":"31","author":"Yilin","year":"2022","journal-title":"J Clin Nurs"},{"key":"R19-20250812","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/JU.0000000000001074","article-title":"Downgrading from biopsy grade group 4 prostate cancer in patients undergoing radical prostatectomy for high or very high risk prostate cancer.","volume":"204","author":"Ranasinghe","year":"2020","journal-title":"J Urol"},{"key":"R20-20250812","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1200\/JCO.2021.39.6_suppl.210","article-title":"Pinpointing uncharacterized prostate cancer in active surveillance patients through mpMRI biopsy.","volume":"39","author":"Greenberg","year":"2021","journal-title":"J Clin Oncol"},{"key":"R21-20250812","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis.","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"key":"R22-20250812","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2214\/AJR.19.22094","article-title":"MRI of the prostate with and without endorectal coil at 3 T: correlation with whole-mount histopathologic gleason score.","volume":"215","author":"Dhatt","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"R23-20250812","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/MOU.0000000000000801","article-title":"mpMRI-targeted biopsy versus systematic biopsy for clinically significant prostate cancer diagnosis: a systematic review and metaanalysis.","volume":"30","author":"Baccaglini","year":"2020","journal-title":"Curr Opin Urol"},{"key":"R24-20250812","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clgc.2020.06.008","article-title":"Accuracy of MRI-guided vs systematic prostate biopsy in patients under active surveillance: a systematic review and meta-analysis.","volume":"19","author":"Baccaglini","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"R25-20250812","first-page":"24","article-title":"Improving MRI diagnosis of prostate cancer - A case study on diffusion weighted imaging (DWI) versus dynamic contrast enhanced (DCE) imaging.","volume":"24","author":"Williamson","year":"2021","journal-title":"Insight"},{"key":"R26-20250812","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/2090598X.2021.1926727","article-title":"Magnetic resonance imaging\/ultrasonography fusion transperineal prostate biopsy for prostate cancer: initial experience at a Middle Eastern tertiary medical centre.","volume":"19","author":"El-Achkar","year":"2021","journal-title":"Arab J Urol"},{"key":"R27-20250812","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/JU.0000000000001476","article-title":"A comparison of prostate cancer detection between visual-estimation (cognitive registration) and image-fusion (software registration) targeted transperineal prostate biopsy.","volume":"205","author":"Khoo","year":"2021","journal-title":"J Urol"},{"key":"R28-20250812","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bju.15118","article-title":"Multiparametric MRI\u2010ultrasound software fusion prostate biopsy \u2013 initial results using a stereotactic robotic assisted transperineal prostate biopsy platform comparing systematic versus targeted biopsy.","volume":"126","author":"Lee","year":"2020","journal-title":"BJU Int"},{"key":"R29-20250812","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/JU.0000000000001523","article-title":"Transperineal prostate biopsy improves the detection of clinically significant prostate cancer among men on active surveillance.","volume":"205","author":"Meyer","year":"2021","journal-title":"J Urol"},{"key":"R30-20250812","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/bju.15554","article-title":"A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: are the models still relevant?","volume":"128","author":"Doan","year":"2021","journal-title":"BJU Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:01:06Z","timestamp":1755018066000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":30,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043049","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}